Compare DJCO & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DJCO | INNV |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.5M | 485.4M |
| IPO Year | N/A | 2021 |
| Metric | DJCO | INNV |
|---|---|---|
| Price | $477.30 | $4.78 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 308.8K | 232.8K |
| Earning Date | 12-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.36 | N/A |
| EPS | ★ 70.22 | N/A |
| Revenue | $79,159,000.00 | ★ $884,662,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | N/A | $9.58 |
| P/E Ratio | $6.56 | ★ N/A |
| Revenue Growth | 10.54 | ★ 12.48 |
| 52 Week Low | $348.63 | $2.60 |
| 52 Week High | $596.60 | $6.26 |
| Indicator | DJCO | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 44.53 |
| Support Level | $422.82 | $4.94 |
| Resistance Level | $501.66 | $5.22 |
| Average True Range (ATR) | 29.25 | 0.40 |
| MACD | 4.49 | -0.05 |
| Stochastic Oscillator | 83.41 | 4.33 |
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.